Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

disease progression

- PMLiVE

Transparency and accountability: tackling opacity and blame head-on

Delivering effective, code-compliant, transparent experiences and communications

- PMLiVE

BenevolentAI raises $115m to fund drug development

Its technology could cut the early stage drug discovery process by four years, says the company

- PMLiVE

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

Will also access Merck’s big-selling Neurobion and the Nasivin nasal decongestant range

- PMLiVE

Health insurers will test blockchain for data handling

Aims to make health records more accurate and reliable

- PMLiVE

Merck KGaA inks deal for Medisafe adherence app

The digital programme will be initially rolled out in Brazil, Russia and Mexico

- PMLiVE

IQVIA partners with Box

Will work on managing content for the life science industry

Implementing eHealth innovation

How Merck’s PMEA-winning progress in new technology  is improving outcomes for young patients

- PMLiVE

Merck and Pfizer set to win NICE backing for Bavencio

The PD-L1 inhibitor is being assessed for the treatment of mMCC patients

- PMLiVE

Merck/Pfizer’s cancer immunotherapy latecomer hits a snag

Bavencio fails a key lung cancer trial

- PMLiVE

Pfizer and IBM’s tech-enabled ‘Parkinson’s house’

Pharma firm looks to technology to help it unlock the doors to breakthrough treatments

Integrating digital biomarkers into precision medicine

Leveraging digital technologies to enhance the clinical evaluation and delivery of precision therapies

- PMLiVE

Merck forges closer ties with Cancer Research UK

Will partake in three research projects covering hit discovery to preclinical candidate selection

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links